A Princeton team has developed a class of light-switchable, highly adaptable molecular tools with new capabilities to control cellular activities. The antibody-like proteins, called OptoBinders, have potential applications including protein purification, the improved production of biofuels, and new types of targeted cancer therapies.
- The male Y chromosome does more than we thought
- Ultrapotent compound may help treat C. diff, reduce recurrence
- High-performance single-atom catalysts for high-temperature fuel cells
- Novel neuroimaging study on dissociative symptoms reveals wounds of childhood trauma
- Historical racial & ethnic health inequities account for disproportionate COVID-19 impact